These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 33672671)

  • 1. Activity of Imipenem, Meropenem, Cefepime, and Sulbactam in Combination with the β-Lactamase Inhibitor LN-1-255 against
    Lasarte-Monterrubio C; Vázquez-Ucha JC; Maneiro M; Arca-Suárez J; Alonso I; Guijarro-Sánchez P; Buynak JD; Bou G; González-Bello C; Beceiro A
    Antibiotics (Basel); 2021 Feb; 10(2):. PubMed ID: 33672671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [In vitro synergistic activity of sulbactam in combination with imipenem, meropenem and cefoperazone against carbapenem-resistant Acinetobacter baumannii isolates].
    Turk Dagi H; Kus H; Arslan U; Tuncer I
    Mikrobiyol Bul; 2014 Apr; 48(2):311-5. PubMed ID: 24819268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mechanism of drug resistance of carbapenems-resistant Acinetobacter baumannii and the application of a combination of drugs in vitro].
    Zhao C; Xie W; Zhang W; Ye Z; Wu H
    Zhonghua Shao Shang Za Zhi; 2014 Apr; 30(2):166-70. PubMed ID: 24989663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic Efficacy of LN-1-255 in Combination with Imipenem in Severe Infection Caused by Carbapenem-Resistant Acinetobacter baumannii.
    Vázquez-Ucha JC; Martínez-Guitián M; Maneiro M; Conde-Pérez K; Álvarez-Fraga L; Torrens G; Oliver A; Buynak JD; Bonomo RA; Bou G; González-Bello C; Poza M; Beceiro A
    Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31383666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of the β-Lactamase Inhibitor LN-1-255 against Carbapenem-Hydrolyzing Class D β-Lactamases from Acinetobacter baumannii.
    Vázquez-Ucha JC; Maneiro M; Martínez-Guitián M; Buynak J; Bethel CR; Bonomo RA; Bou G; Poza M; González-Bello C; Beceiro A
    Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28807908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity of Sulbactam-Durlobactam and Comparators Against a National Collection of Carbapenem-Resistant
    Petropoulou D; Siopi M; Vourli S; Pournaras S
    Front Cell Infect Microbiol; 2021; 11():814530. PubMed ID: 35127562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli.
    Zhanel GG; Golden AR; Zelenitsky S; Wiebe K; Lawrence CK; Adam HJ; Idowu T; Domalaon R; Schweizer F; Zhanel MA; Lagacé-Wiens PRS; Walkty AJ; Noreddin A; Lynch Iii JP; Karlowsky JA
    Drugs; 2019 Feb; 79(3):271-289. PubMed ID: 30712199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting Multidrug-Resistant
    Barnes MD; Kumar V; Bethel CR; Moussa SH; O'Donnell J; Rutter JD; Good CE; Hujer KM; Hujer AM; Marshall SH; Kreiswirth BN; Richter SS; Rather PN; Jacobs MR; Papp-Wallace KM; van den Akker F; Bonomo RA
    mBio; 2019 Mar; 10(2):. PubMed ID: 30862744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of sulbactam/durlobactam against global isolates of carbapenem-resistant Acinetobacter baumannii.
    Seifert H; Müller C; Stefanik D; Higgins PG; Miller A; Kresken M
    J Antimicrob Chemother; 2020 Sep; 75(9):2616-2621. PubMed ID: 32516359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Molecular characterization of beta-lactamase-associated resistance in Acinetobacter baumannii strains isolated from clinical samples].
    Keskin H; Tekeli A; Dolapci İ; Öcal D
    Mikrobiyol Bul; 2014 Jul; 48(3):365-76. PubMed ID: 25052103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sulbactam Enhances in vitro Activity of β-Lactam Antibiotics Against
    Wang L; Chen Y; Han R; Huang Z; Zhang X; Hu F; Yang F
    Infect Drug Resist; 2021; 14():3971-3977. PubMed ID: 34611414
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Karlowsky JA; Hackel MA; McLeod SM; Miller AA
    Antimicrob Agents Chemother; 2022 Sep; 66(9):e0078122. PubMed ID: 36005804
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Guo Y; Han R; Jiang B; Ding L; Yang F; Zheng B; Yang Y; Wu S; Yin D; Zhu D; Hu F;
    Microbiol Spectr; 2022 Aug; 10(4):e0185422. PubMed ID: 35862963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C6 Hydroxymethyl-Substituted Carbapenem MA-1-206 Inhibits the Major
    Stewart NK; Toth M; Alqurafi MA; Chai W; Nguyen TQ; Quan P; Lee M; Buynak JD; Smith CA; Vakulenko SB
    mBio; 2022 Jun; 13(3):e0036722. PubMed ID: 35420470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imipenem-Relebactam and Meropenem-Vaborbactam: Two Novel Carbapenem-β-Lactamase Inhibitor Combinations.
    Zhanel GG; Lawrence CK; Adam H; Schweizer F; Zelenitsky S; Zhanel M; Lagacé-Wiens PRS; Walkty A; Denisuik A; Golden A; Gin AS; Hoban DJ; Lynch JP; Karlowsky JA
    Drugs; 2018 Jan; 78(1):65-98. PubMed ID: 29230684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of cefepime combined with sulbactam against clinical isolates of carbapenem-resistant Acinetobacter spp.
    Tong W; Wang R; Chai D; Li Z; Pei F
    Int J Antimicrob Agents; 2006 Nov; 28(5):454-6. PubMed ID: 16987639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antimicrobial resistance and existence of metallo-beta-lactamase in Acinetobacter species isolated from adult patients].
    Eser OK; Ergin A; Hasçelik G
    Mikrobiyol Bul; 2009 Jul; 43(3):383-90. PubMed ID: 19795613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bulgecin A as a β-lactam enhancer for carbapenem-resistant
    Skalweit MJ; Li M
    Drug Des Devel Ther; 2016; 10():3013-3020. PubMed ID: 27703329
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Soudeiha MAH; Dahdouh EA; Azar E; Sarkis DK; Daoud Z
    Front Cell Infect Microbiol; 2017; 7():209. PubMed ID: 28596943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emergence of Carbapenem-Hydrolyzing Oxacillinases in Acinetobacter baumannii in Children from Croatia.
    Lukić-Grlić A; Kos M; Žižek M; Luxner J; Grisold A; Zarfel G; Bedenić B
    Chemotherapy; 2019; 64(4):167-172. PubMed ID: 31707391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.